digital health startups weight loss glp-1 Perspectives: The new “lean”: how drugs will affect Healthtech What to Know About New

GLP-1 therapies and hair loss: A systematic review of current evidence and implications for counseling

The reduced GSH could be transported back to cytosol where they could be re-oxidized

Shortened to RIA, Yalow and Beron's technique helped to reawaken research into incretin

PMID 16866106

Both immediate-release exenatide (Byetta) and extended-release exenatide (Bydureon BCise) have established gastrointestinal side effect profiles, though they are less commonly prescribed today due to the availability of more convenient once-weekly alternatives

A large meta-analysis by Sagoe et al., encompassing 271 studies, estimated the average lifetime prevalence of androgen use to be 6.4% among men and 1.6% among women